tiprankstipranks
Lotus Pharmaceuticals Inc (LTUS)
OTHER OTC:LTUS
US Market
Holding LTUS?
Track your performance easily

Lotus Pharmaceuticals (LTUS) Financial Statements

4 Followers

Lotus Pharmaceuticals Financial Overview

Lotus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is ―; Lotus Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 11Jun 11Mar 11Dec 10Sep 10
Income Statement-
Total Revenue$ 19.04M$ 18.69M$ 12.92M$ 20.73M$ 18.30M
Gross Profit$ 3.31M$ 4.89M$ 6.15M$ 11.09M$ 10.38M
EBIT$ 1.32M$ 1.84M$ 2.30M$ -3.72M$ 6.96M
EBITDA$ 1.73M$ 2.25M$ 2.70M$ -2.81M$ 7.41M
Net Income Common Stockholders$ 1.25M$ 1.77M$ 2.24M$ -3.53M$ 6.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 158.91K$ 886.45K$ 1.31M$ 1.34M$ 897.65K
Total Assets$ 120.16M$ 114.49M$ 107.75M$ 103.18M$ 103.83M
Total Debt$ 5.41M$ 5.36M$ 5.28M$ 5.24M$ 5.17M
Net Debt$ 5.25M$ 4.48M$ 3.96M$ 3.90M$ 4.28M
Total Liabilities$ 20.70M$ 17.24M$ 13.82M$ 14.16M$ 12.94M
Stockholders Equity$ 99.45M$ 97.25M$ 93.93M$ 89.02M$ 90.89M
Cash Flow-
Free Cash Flow$ -727.81K$ -440.62K$ -37.44K$ 402.92K$ -203.15K
Operating Cash Flow$ 3.92M$ 3.09M$ 3.56M$ 7.80M$ 10.07M
Investing Cash Flow$ -4.65M$ -3.53M$ -3.60M$ -7.39M$ -10.27M
Financing Cash Flow$ 0.00---$ 0.00
Currency in USD

Lotus Pharmaceuticals Earnings and Revenue History

Lotus Pharmaceuticals Debt to Assets

Lotus Pharmaceuticals Cash Flow

Lotus Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis